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Multiplex Method for Simultaneous Serological Detection of Porcine
Reproductive and Respiratory Syndrome Virus and Porcine Circovirus
Type 2
Abstract
Porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) are
major contributors to the porcine respiratory disease complex (PRDC). Routine serological diagnosis and
surveillance play an important role in the prevention of PRDC, as it is a leading cause of economic losses to
the swine industry. We herein describe an advanced microsphere-based immunoassay that permits the
simultaneous detection of antibodies to PCV2 and PRRSV, thereby reducing the time and effort involved in
testing. Recombinant PRRSV nucleoprotein antigen and the PCV2 capsid antigen were coupled to
fluorophore-dyed beads with distinct spectral addresses. Weekly serum samples from 72 pigs that were
experimentally exposed to either PCV2, PRRSV, or both PCV2 and PRRSV were used to validate the
microbead assay (MBA) in comparison with the “gold standard” enzyme-linked immunosorbent assays. The
kinetics of the PCV2- and PRRSV-specific antibody responses measured by the microbead assay were
comparable to those of the standard assays; Spearman's rank correlations were 0.72 (P < 0.001) for PRRSV
and 0.80 (P < 0.001) for PCV2. Diagnostic sensitivity and specificity were determined using field sera whose
positive or negative status was determined by the standard tests. The diagnostic sensitivity and specificity were
both 98% for PCV2 and were 91% and 93%, respectively, for PRRSV (kappa coefficients, 0.85 and 0.67 for
PCV2 and PRRSV, respectively). Multiplexing did not interfere with assay performance or diagnostic
sensitivity. Therefore, the described study demonstrates proof of concept for the development of more
versatile and economical microbead array-based multiplex serological test panels for veterinary use.
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Porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) are
major contributors to the porcine respiratory disease complex (PRDC). Routine serological diagnosis and
surveillance play an important role in the prevention of PRDC, as it is a leading cause of economic losses to
the swine industry. We herein describe an advanced microsphere-based immunoassay that permits the simul-
taneous detection of antibodies to PCV2 and PRRSV, thereby reducing the time and effort involved in testing.
Recombinant PRRSV nucleoprotein antigen and the PCV2 capsid antigen were coupled to fluorophore-dyed
beads with distinct spectral addresses. Weekly serum samples from 72 pigs that were experimentally exposed
to either PCV2, PRRSV, or both PCV2 and PRRSV were used to validate the microbead assay (MBA) in
comparison with the “gold standard” enzyme-linked immunosorbent assays. The kinetics of the PCV2- and
PRRSV-specific antibody responses measured by the microbead assay were comparable to those of the
standard assays; Spearman’s rank correlations were 0.72 (P < 0.001) for PRRSV and 0.80 (P < 0.001) for
PCV2. Diagnostic sensitivity and specificity were determined using field sera whose positive or negative status
was determined by the standard tests. The diagnostic sensitivity and specificity were both 98% for PCV2 and
were 91% and 93%, respectively, for PRRSV (kappa coefficients, 0.85 and 0.67 for PCV2 and PRRSV, respec-
tively). Multiplexing did not interfere with assay performance or diagnostic sensitivity. Therefore, the de-
scribed study demonstrates proof of concept for the development of more versatile and economical microbead
array-based multiplex serological test panels for veterinary use.
Porcine respiratory disease complex (PRDC) is a multifac-
torial disease syndrome which can involve several etiological
agents. Therefore, early detection and prevention of coinfec-
tions are important aspects of managing PRDC. Growing pig-
lets are the most severely affected, with PRDC resulting in
morbidity which can be as high as 70%, poor feed conversion,
and lower growth rates. Porcine circovirus type 2 (PCV2) and
porcine reproductive and respiratory syndrome virus (PRRSV)
are the most frequently associated with PRDC. Swine influ-
enza viruses (SIVs), porcine respiratory coronavirus, Myco-
plasma spp., Actinobacillus pleuropneumoniae, Streptococcus
suis, and Pasteurella spp. may also be etiological agents (3, 14,
20, 36).
Due to the severe economic losses associated with PRDC,
serological testing for agents involved in PRDC comprises a
major part of the diagnostic testing carried out in swine-dense
regions. In addition to the fact that multiple agents can be
simultaneously involved in causing PRDC, agents like SIV and
A. pleuropneumoniae have several subtypes or serotypes which
are antigenically distinct (24, 37). In theory, a comprehensive
serological test panel for the differential diagnosis of PRDC
should incorporate tests for several different pathogens. The
tests of choice for each of these agents could potentially in-
clude several different assay formats, such as the enzyme-
linked immunosorbent assay (ELISA) and the more laborious
complement fixation tests, hemagglutination inhibition, and
virus neutralization tests (18). Therefore, multiplex testing
platforms which can save labor, time, and cost by providing
information about more than one pathogen from a single test
run will be important as diagnostic tools of the future. While
several multiplex tests have been developed for nucleic acid-
based detection of pathogens (15, 29, 38), very few multiplex
tests are available for antibody detection, especially for veter-
inary use (1, 8, 21).
The microbead array (MBA)-based technology (Luminex
Corp., Austin, TX) consists of color-coded microbeads which
have distinct spectral addresses enabling laser-mediated detec-
tion in a flow cytometer. The beads can be coupled to antigens,
antibodies, or nucleic acids for the specific detection of cognate
antibodies, antigens (such as cytokines), or DNA for diagnostic
and basic research applications (28). Up to 100 different ana-
lytes can be detected simultaneously with the Luminex xMap
technology. Therefore, the primary advantages of this technol-
ogy are its multiplexing and high-throughput capabilities.
Other advantages include savings of cost, time, and labor and
improved assay performance. Interest in the MBA technology
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as a versatile tool for clinical microbiology with both human
and animal applications is widespread and increasing (1, 13, 21,
23, 34). In this study, we have harnessed the MBA technology
to develop a dual serological detection test for PCV2 and
PRRSV (PCV2/PRRSV MBA), as a first step toward the de-
velopment of a comprehensive multiplex test panel for PRDC.
MATERIALS AND METHODS
PCV2 and PRRSV antigens. The immunogenic PCV2 capsid protein which is
encoded by open reading frame 2 (orf2) was expressed in the baculovirus system
as previously described (27). Nonrecombinant baculovirus antigen was used as a
background control and is designated the wild-type (WT) antigen in this study.
PRRSV nucleoprotein (N protein) was produced in a bacterial expression system
as a 6His-tagged protein and was purified by nickel affinity chromatography
(19).
PCV2 and PRRSV standard ELISAs for validation of PCV2/PRRSV MBA.
The optimization and validation of the orf2-based PCV2 ELISA have been
previously described (27). A slightly modified version is currently offered at the
Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL). Briefly, 16
ng of PCV2 Orf2 and 5.2 ng of WT antigen/well are coated on adjacent wells of
an Immunolon plate (Dynex, Chantilly, VA). A 1:100 dilution of test serum in
blocking buffer consisting of 5% skim milk powder is incubated on the plates for
30 min, followed by the addition of anti-swine horseradish peroxidase conjugate
at 1:2,500. After incubation with the substrate and stopping of the reaction with
0.1 N H2SO4, plates are read at 450 nm. The corrected optical density (COD)
value of each sample is derived by subtraction of the WT value from the orf2
value for the given sample. The COD value of each sample is divided by the COD
value of the positive-control serum sample and expressed as a sample COD-to-
positive-control COD (S/P) ratio. A cutoff value of 0.3 was used to distinguish
between positive and negative samples. For the purposes of this study, samples
with values between 0.2 and 0.3 were classified as suspect. As described by
Nawagitgul et al. (27), the assay had a sensitivity of 91% and a specificity of 93%.
A well-accepted commercial ELISA kit (Herdchek PRRSV 2XR kit; IDEXX,
Westbrook, ME) was used for the detection of PRRSV antibodies following the
manufacturer’s instructions. A manufacturer prescribed S/P cutoff value of 0.4
was used to distinguish between positive and negative samples. According to a
previous study, the sensitivity and specificity values for the assay were determined
to be 97.4% and 99.6%, respectively (4). However, users of the 2XR kit have
consistently recognized and documented unexpected positive results (4, 7, 17).
Serum samples for assay validation. Archived experimental serum samples
from a previous study (33) were used to validate the PCV2/PRRSV MBA.
Seventy-two PCV2-, PRRSV-, and SIV-free pigs were randomly assigned to four
groups. Group 1 piglets (n  12) served as uninfected controls; group 2 piglets
(n 24) were divided into two subgroups. Each pig in one subgroup of 12 piglets
was inoculated with 104.5 50% tissue culture infective doses (TCID50) of the
PCV2 wild-type virus strain 40895 (6) stock (3 ml intranasally and 2 ml intra-
muscularly), while the 12 pigs in the other subgroup were administered a mutant
virus which had an altered interferon-stimulated response element (ISRE) in its
genome (32). We have previously shown that the mutant virus and wild-type
PCV2 are antigenically indistinguishable by the “gold standard” PCV2 ELISA
(33). Therefore, no distinction is made between the two viruses for the purpose
of validation of the PCV2/PRRSV MBA in this study. Data from animals in-
fected with either the wild-type virus or the mutant PCV2 have been combined
for analysis. Group 3 piglets (n  12) were inoculated intranasally with 106.0
TCID50 of PRRSV strain VR2385 stock; group 4 pigs (n  24) were coinfected
with both PCV2 and PRRSV as described for groups 2 and 3. At 14 days
postinfection (dpi), 6 pigs from groups 1 and 3 and 12 pigs each from the
remaining groups were killed. All pigs were euthanized at 28 dpi. Sera which
were collected just prior to infection at 1 dpi and weekly thereafter were used to
validate and optimize the PCV2/PRRSV MBA.
The diagnostic sensitivity and specificity of the PCV2/PRRSV MBA were
assessed using field samples (11, 12). Three hundred eighty-eight field samples
were analyzed, and 226 were classified PCV2 negative (S/P  0.2), 28 suspect
(S/P  0.2 to 0.3), and 134 positive (S/P  0.3) on the basis of the in-house gold
standard PCV2 ELISA. The selected negative samples had S/P values that
ranged from0.108 to 0.204, and the positive samples had S/P values that ranged
from 0.296 to 3.13.
Three hundred seventy-eight samples were analyzed by the commercial Herd-
Chek PRRS 2XR ELISA. Of these, 262 were PRRSV negative with S/P values
that ranged from 0.00 to 0.399 and 116 samples were positive with S/P values that
ranged from 0.404 to 4.26. There was no suspect range assigned to these samples,
as it was not prescribed by the ELISA kit manufacturer. There were 124 samples
that were assessed on both the PCV2 and PRRSV standard ELISAs (see Fig. 3).
Selected samples from a previously published study were used to determine the
cross-reactivity of the PCV2 and PRRSV antigens to SIV (22) (Table 1).
PCV2/PRRSV duplex microbead assay. Twelve micrograms of the PCV2 Orf2
antigen, 8 g of the PRRSV N-protein antigen, and 6 g of the WT antigen were
each coupled to fluorophore-dyed microbead numbers 65, 61, and 48 (Bio-Rad,
Hercules, CA) as described by the manufacturer. Bead counts were verified on
a hemocytometer. A total of 2,500 beads/well/antigen were used for all assays.
The microbead assay was carried out as described previously, with modifications
(1, 8, 34). The 96-well filter plates (Millipore, Billerica, MA) were blocked with
PBN buffer (phosphate-buffered saline [PBS], pH 7.4, with 1% bovine serum
albumin) for 2 min. Test sera were diluted 1:100 in PBN buffer and added to the
filter plate. A total of 2,500 coupled beads for each of the three antigens used in
the study were added to the wells. The plate was incubated at room temperature
for 30 min, followed by three washes with PBS-Tween (PBS-T) using a vacuum
manifold. Biotin-labeled anti-swine IgG H&L chain (Kirkegaard & Perry Lab-
oratories, San Diego, CA) was added at 1:2,500, and the plate was incubated at
room temperature for 30 min. Plates were washed three times with PBS-T. Fifty
microliters of streptavidin conjugated with Rhodophyta phycoerythrin (Invitro-
gen, Valencia, CA) at a 1:100 dilution in PBN buffer was added for 30 min. The
plate was again washed twice in a vacuum manifold. The beads were resuspended
in 125 l of PBN buffer. Seventy-five microliters of the resuspended beads was
transferred to a clear U-bottom plate (Thermo Scientific, Worcester, MA).
Plates were read in the Luminex 100 instrument using Bioplex (version 5.0)
software (Bio-Rad, Hercules, CA). The median fluorescence intensity unit
(MFU) for each of the three antigen-coupled beads in the wells was the median
value for a count of 100 beads detected by the dual-flow laser cytometer (1, 8,
34). PCV2/PRRSV MBA data for the experimental samples used in this study
are presented as the average of the MFU values for each treatment group.
Therefore, they are denoted the average fluorescence intensity (AFU) value (see
Fig. 1 and Table 2). A panel of seven selected serum samples was used as a
control in all assays (Table 1).
Optimization of PCV2/PRRSV MBA. Three spectrally distinct microbead pop-
ulations were selected for conjugation of PRRSV N protein, PCV2 Orf2, and
WT protein at each of three amounts: 6 g, 8 g, and 12 g. Three strongly
positive and three negative experimental serum samples from 28 dpi in the study
described previously (20) were pooled. Two SIV-positive and -negative samples
each were included to control for cross-reactivity, as SIV is another common
causative agent of PRDC. A partial checkerboard titration with 1:50, 1:100, and
1:200 dilutions of the primary antibodies and 1:500, 1:1,000, 1:1,500 1:2,000, and
1:2,500 dilutions of the biotin-labeled anti-swine IgG conjugate was assessed by
the PCV2/PRRSV MBA.
Interassay variation was determined using the panel of seven control serum
samples (Tables 1 and 2) which were positive for either PCV2 or PRRSV, or
both, as previously described (24). One sample that was also positive for SIV was
used to rule out cross-reactivity to SIV. Two of the seven controls were created
by pooling to demonstrate that detection was not affected by either dilution of
the positives or the presence of antibodies to more than one analyte. The samples
were assessed in duplicate over eight different runs. Analytical specificity was
evaluated as cross-reactivity between PCV2, PRRSV, and SIV. Intra-assay vari-
ation was measured by testing selected negative, low-positive, and high-positive
sera in duplicate in different locations on the same plate. The coefficient of
variation (COV) between readings for each sample was calculated as a measure
of assay variation (11, 12).
TABLE 1. Results for control samples used to measure interassay
variation of PCV2/PRRSV MBA
Sample
Result fora:
PCV2 PRRSV SIV
Control 1 P N N
Control 2 N N N
Control 3 (pooled controls 1 and 2) P N N
Control 4 (PCV2 and PRRSV positive) P P N
Control 5 (PCV2 positive) P N N
Control 6 (SIV, PCV2, and PRRSV positive) P P P
Control 7 (pooled controls 4, 5, and 6) P P P
a P, positive; N, negative.
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Statistical analysis. For the experimental samples, the correlation between the
standard ELISAs and the PCV2/PRRSV MBA was assessed by using Spearman’s
correlation coefficient. To determine whether multiplexing interfered with de-
tection of either analyte, the effect of the presence of PRRSV antibodies on
MBA detection of PCV2 antibodies and vice versa was assessed by the Wilcoxon
two-sample rank-sum test. For field samples, receiver operating characteristics
(ROC) analysis (9–11) was carried out for each analyte using the ELISA as the
standard test to determine the positive and negative status of a sample. Sensi-
tivity- and specificity-controlled positive, negative, and suspect cutoff values were
selected on the basis of the ROC analysis. Positive predictive values, negative
predictive values, sensitivities, and specificities were calculated at the selected
cutoff values. Agreement between dichotomized ELISA and dichotomized
PCV2/PRRSV MBA data was assessed using the proportion of agreement and
the kappa coefficient association.
RESULTS
Optimization of PCV2/PRRSV MBA. On the basis of the
results of the partial checkerboard titration, 12 g of Orf2
antigen, 6 g of WT antigen, and 8 g of PRRSV N-protein
antigen were determined to be optimal for bead coupling. A
1:100 dilution of the test serum provided an adequate dynamic
range with optimal sensitivity for the detection of low-positive
samples. The working conjugate dilution was set at 1:2,500.
The lack of cross-reactivity of the PCV2 antigen to porcine
parvovirus and PRRSV antibodies has been previously de-
scribed (27). With a view to expanding multiplex testing capa-
bilities using the PCV2/PRRSV MBA, we also examined the
cross-reactivities of the selected antigens to anti-SIV antibod-
ies. The analytical specificity of the assay was satisfactory, as no
cross-reactivity between PCV2-, PRRSV-, and SIV-positive
sera was detected on the PCV2/PRRSV MBA.
Determination of repeatability. The interassay variation
measured as the coefficient of variation derived from eight runs
of a panel of seven selected control samples showed that run-
to-run variation for all seven samples was very low (Tables 1
and 2).
Within-assay variation of samples on the PCV2/PRRSV
MBA, which was measured by placing the same sample at
different locations on a plate, was also negligible. A negative
sample had COV values of 0.08 and 0.04 for PRRSV and
PCV2, respectively. A low-positive sample had COV values of
0.009 and 0.03 for PRRSV and PCV2, respectively. The high-
est COV values obtained for five other samples that were high
positives for both analytes on the standard ELISAs were 0.02
and 0.07 for PRRSV and PCV2, respectively.
Kinetics of antibody responses in experimentally infected
pigs. The kinetics of antibody responses in experimentally in-
fected pigs measured by the PCV2/PRRSV MBA were com-
parable to the kinetics of the responses measured by the stan-
dard ELISAs for PCV2 and PPRSV (Fig. 1). The analytical
sensitivity measured by the earliest detection of specific anti-
bodies occurred between 3 dpi and 10 dpi for PCV2 in both
assays. Similarly, for PRRSV the earliest detection of a specific
response was between 3 dpi and 7 dpi on both assays. There-
after, the pattern of detection of incremental increases over
time points was similar for both the PCV2/PRRSV MBA and
ELISAs for PCV2 and PRRSV until 21 dpi. Between 21 dpi
and 28 dpi, there was a difference between the PCV2/PRRSV
MBA and ELISAs in the PRRSV antibody detection patterns.
The PRRSV antibody response appeared to show an increas-
ing trend in the ELISA, while it had reached a plateau and was
decreasing in the PCV2/PRRSV MBA. The combined detec-
tion of PCV2 and PRRSV antibodies in coinfected animals was
not affected by multiplexing, as the trend lines for the dually
infected animals remained similar for the gold standard
ELISAs and the PCV2/PRRSV MBA. Samples from mock-
infected animals and samples from 1 dpi remained negative on
both assays. The median blank fluorescence intensity values
measured in wells in which the primary antibody was omitted
were negligible (data not shown).
Good agreement was observed between the PCV 2 and
PRRSV ELISAs and PCV2/PRRSV MBA at 7 dpi, which is
considered a critical time point for determining seroconversion
for PRRSV (Spearman’s rank correlation  0.72, P  0.001).
Similarly, for PCV2 the Spearman’s rank correlation was 0.80
(P  0.001) at 14 dpi. This time point was used for evaluation
as seroconversion is usually slower for PCV2. When the S/P
ratios of individual samples measured by the standard ELISAs
were plotted against the median fluorescence units obtained
from the PCV2/PRRSV MBA, the relationship was found to
be linear at 7, 14, and 21 dpi, with the plots for a majority of
samples clustering around the trend line (Fig. 2).
We had previously determined that antibody responses in
dually infected animals were not significantly different from
those in singly infected animals at 21 and 28 dpi using the
standard ELISA (29). The PCV2/PRRSV MBA also showed
that PCV2 and PRRSV antibody responses in singly infected
pigs were not different from those in the dually infected pigs at
21 and 28 dpi (Wilcoxon’s rank sum test, P  0.05), indicating
that multiplexing did not interfere with detection of either
analyte.
ROC analysis for determination of cutoff limits. To avoid
compromising assay sensitivity or specificity by selecting cutoff
values based exclusively on negative samples, detailed ROC
TABLE 2. Interassay variation of PCV2/PRRSV MBA
Sample
AFU
PCV2 Orf2 WT PRRSV N protein
Mean Median COV Mean Median COV
Control 1 1,370.67 1,304.00 0.20 547.67 488.50 0.29
Control 2 13.06 19.00 3.27 74.72 3.00 2.25
Control 3 (pooled controls 1 and 2) 1,053.39 1,041.00 0.26 373.61 354.00 0.35
Control 4 (PCV2 and PRRSV positive) 1,593.83 1,456.00 0.21 22,393.00 22,595.00 0.07
Control 5 (PCV2 positive) 1,686.67 1,641.50 0.28 21.11 26.00 2.28
Control 6 (SIV, PCV2, and PRRSV positive) 4,836.67 4,980.00 0.30 21,789.83 24,020.50 0.17
Control 7 (pooled controls 4, 5, and 6) 3,228.50 3,484.50 0.17 22,154.28 23,267.50 0.10
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analysis, which takes into account both the positive and the
negative reference populations in the data set, was carried out.
The areas under the curve (AUCs) were 0.97 for PCV2 and
0.92 for PRRSV. The positive and negative cutoff values se-
lected on the basis of the ROC analysis results for PCV2 were
200 MFU for negative samples, 200 to 400 for suspect sam-
ples, and 400 MFU for positive samples. The diagnostic
sensitivity and specificity were both 98% for the PCV2 MBA.
FIG. 1. Kinetics of antibody responses in pigs that were singly or dually infected with PCV2 and/or PRRSV. (A) Antibody responses measured
by the gold standard PCV2 ELISA; (B) antibody responses measured by the PCV2 MBA; (C) antibody responses measured by the gold standard
PRRSV ELISA; (D) antibody responses measured by the PRRSV MBA.
FIG. 2. Scatter plots showing the linear relationship between the gold standard ELISAs and the PCV/PRRSV MBA. Data depicted are for
samples collected from pigs that were experimentally infected with PCV2 or PRRSV, or both. PCV2 ELISA OD values (x axis) and the PCV2
MBA median fluorescence intensity values (Luminex) (y axis) are shown on the left panel. PRRSV ELISA OD values (x axis) and the PPRRSV
MBA median fluorescence intensity values (Luminex) (y axis) are shown on the right panel.
VOL. 49, 2011 MULTIPLEX DETECTION OF SWINE RESPIRATORY PATHOGENS 3187
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For the PRRSV MBA, the cutoff values were4,000 MFU for
negative samples, 4,000 to 7,000 for suspect samples, and
7,000 MFU for positive samples. The diagnostic sensitivity
and specificity were 93% and 91%, respectively, for the
PRRSV MBA. On the basis of optimal sensitivity and speci-
ficity values, the positive/negative cutoff values were selected to
be 400 MFU for PCV2 and 7,000 MFU for PRRSV. The kappa
statistic values, which represent agreement with the standard
ELISAs, were 0.79 (95% confidence interval [CI], 0.74 to 0.84)
and 0.67 (95% CI, 0.60 to 0.74) for the PCV2 and PRRSV
MBAs, respectively. At these cutoffs, the diagnostic sensitivity
and specificity for the PCV2 MBA were both 98%, while they
were 93 and 91%, respectively, for the PRRSV MBA. On the
basis of the results for the field samples, the positive and
negative predictive values for the PCV2 MBA were both 98%
and the accuracy of the test was 92%. The positive and nega-
tive predictive values for the PRRSV MBA were 89% and
73%, respectively, and the accuracy of the test was 82%.
Validation of PCV2/PRRSV MBA with field samples. To
validate the PCV2 MBA, 388 field samples were assessed by
the standard PCV2 ELISA and the PCV2/PRRSV MBA. A
comparison of the distribution of negative, suspect, and posi-
tive samples measured by the PCV2/PRRSV MBA and gold
standard ELISA is shown in Fig. 3. While 226 of the samples
were classified negative on the basis of the ELISA, 240 samples
were classified negative on the basis of the PCV2/PRRSV
MBA (Fig. 3). One hundred thirty-four samples were classified
positive on the basis of the ELISA, while 105 of these samples
were classified positive on the basis of the PCV2/PRRSV
MBA. Twenty-eight samples were classified suspect using the
ELISA, while 43 samples were classified suspect on the basis of
the PCV2/PRRSV MBA cutoffs.
The dynamic range of the PCV2/PRRSV MBA was assessed
by selecting samples that ranged from low positives (S/P 0.3)
to high positives (S/P  3.1) on the standard ELISA. The two
assays were comparable, as the average MFU values for field
samples that were classified negative by the standard PCV2
ELISA were also low on the PCV2/PRRSV MBA (50.17 
110.11), while the average MFU value for the suspect samples
was 292.59  66.33. The highest MFU recorded with the
PCV2/PRRSV MBA for the positive samples was 5,702, with a
mean value of 1,120.
Similarly, 378 field samples that included low to high posi-
tives on the PPRSV ELISA were analyzed by the PCV2/
PRRSV MBA. On the basis of the cutoff of the commercial
ELISAs, 262 of the analyzed samples were classified negative
and the remaining 116 samples ranged from low to high pos-
itive. On the basis of the PCV2/PRRSV MBA, 213 samples
were classified negative, 51 suspect, and 114 positive. The dy-
namic ranges for both assays were similar, as the average of
the MFU values for the negative samples was 3,335.56
(5,421.40), while the median value was 1,425.00. The average
MFU value for positive samples was 12,680.48 (7,796.72),
and the median value was 11,181.00.
Of the 130 samples that were analyzed by both the PCV2
and PRRSV standard ELISA, samples that were negative on
the ELISAs had very low MFU values on the PCV2/PRRSV
MBA as well. Samples that were positive for both analytes on
the standard ELISAs were also positive on the PCV2/PRRSV
MBA, with average MFU values of 1,189.83 and 2,2700.67 for
PCV2 and PRRSV, respectively. Therefore, data generated
from field samples reconfirmed conclusions based on the ex-
perimental samples; i.e., multiplexing did not interfere with
detection of either analyte.
DISCUSSION
Unlike human medicine, the detection of antibodies to mul-
tiple pathogens from a single test is of particular value in
veterinary medicine, where herd health monitoring relies on
statistics-based sampling of a small proportion of the total
population to minimize cost. Rarely are entire swine herds
screened to monitor for selected pathogens (26). Multiplex
serology may also be of special value to determine the optimal
FIG. 3. Distribution of the number of positive (POS), suspect (SUS), and negative (NEG) field samples, as classified by the gold standard
ELISAs and the MBA at the cutoffs selected by ROC analysis. (A) Comparison of PCV2 ELISA and MBA; (B) comparison of PRRSV ELISA
and MBA.
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timing of multivalent vaccine administration after waning of a
maternal antibody response and to monitor the duration of
vaccinal immunity (16, 35). Multiplex serology plays an impor-
tant role in clinical differential diagnosis and does so more for
economically important swine diseases where multiple anti-
genic subtypes or serotypes are involved, e.g., SIV infection,
leptospirosis, and A. pleuropneumoniae infection (24). To the
best of our knowledge, this study is the first to describe an
advanced multiplex antibody detection assay for economically
important swine viruses.
The performance of our PCV2/PRRSV MBA was similar to
that of the gold standard ELISAs in sensitivity of detection of
both PCV2 and PRRSV in sera with experimentally generated
viral infections. However, at later time points, where the mag-
nitude of the antibody response is higher, there were differ-
ences in the patterns of detection between the standard tests
and the PCV2/PRRSV MBA. These findings indicate that the
dynamic ranges of the two assays differed at the higher end.
However, this difference was not statistically significant, based
on Spearman’s correlation coefficient values of 0.72 and 0.80
for PCV2 and PRRSV, respectively. Since the diagnostic value
of serological testing is primarily to differentiate negative and
positive, the practical utility of the PCV2/PRRSV MBA was
comparable to that of the standard tests. In situations where
the strength of the antibody response is important, a titration
curve can be utilized. The PCV2 ELISA rather than the ani-
mal’s presumed true-positive status based on experimental in-
fection was used as the standard for the analysis of experimen-
tal samples because the true status of the animal at between 7
dpi and 14 dpi, when seroconversion occurs, is variable until
the titers are high enough for the animal to become clearly
positive. As the standard ELISA cutoffs have already been
validated to accommodate such samples in the gray zone (27),
the PCV2/PRRSV MBA was validated by comparison to the
standard ELISA and not the presumed true-positive status of
the animal.
Assessment of the diagnostic performance of the PCV2/
PRRSV MBA with field samples whose status was previously
determined by the standard ELISAs showed excellent agree-
ment for the PCV2 MBA with the standard test. The PRRSV
MBA had a kappa statistic value of 0.67, which indicated good
agreement with the standard test. The negative predictive
value for the test was 73% and the accuracy was 82%. The
standard PRRSV ELISA is a categorical test that classifies
samples as either positive or negative and has no assigned
suspect range. The relatively high cutoff value of 0.4 was prob-
ably selected to avoid unexpected positive reactions (3, 7, 17,
30). However, having a relatively high cutoff value would lead
to suspect samples being classified negative by the commercial
kit, thus explaining the less than desirable negative predictive
value for the MBA and the excellent agreement of the PRRSV
ELISA and MBA on classification of positive samples. More-
over, the N-protein antigen used in this study was derived from
North American PRRSV strain VR2332. It is known that the
N proteins of the American and European-like PRRSV iso-
lates share only about 65% identity and have some dissimilar
epitopes (5, 25). Therefore, future plans to incorporate the N
protein derived from a type I PRRSV isolate into the PCV2/
PRRSV MBA might improve the sensitivity and assay perfor-
mance for field samples where antibodies to both strains may
be present. Similarly, taking into account the emergence of
PCV type 2b in U.S. swine populations, addition of the PCV2b
capsid protein to the assay may improve the umbrella of de-
tection (2, 31). The nsp7 protein of PRRSV has been reported
to be successful in distinguishing unexpected positive samples
(4). To improve the sensitivity and specificity of detection by
the PCV2/PRRSV MBA, we tested the PRRSV nsp2p pro-
tein’s ability to distinguish the unexpected false-positive sam-
ples. However, no clear differential recognition patterns were
obvious (unpublished data).
Selecting a single arbitrary cutoff value entirely on the basis
of negative samples could result in a loss of sensitivity and
increased assay variation (8). Therefore, the nonparametric
ROC analysis, which is based on both the positive and the
negative reference samples, was used to calculate cutoffs to
distinguish between positive and negative samples (9, 10). The
specificity was plotted against sensitivity for the PCV2/PRRSV
MBA at multiple AFU values. The working assay cutoffs were
selected by comparison of the best sensitivity and specificity
values of multiple AFUs. The area under the curve, which is a
measure of the diagnostic accuracy of the test (12), was ac-
ceptable for both the PRRSV and PCV2 MBAs at values of
0.97 and 0.92, respectively. While the negative predictive value
of the PRRSV MBA could have been improved by lowering
the cutoff value of 7,000 AFU, the selected cutoff was preferred
to retain specificity even at the cost of sensitivity. Although the
commercial PRRSV ELISA does not have a suspect range, to
avoid any possible error in classifying samples positive or neg-
ative, a suspect range was selected for the PCV2/PRRSV
MBA. The status of samples that fall in this zone should be
confirmed by additional testing.
In summary, we have developed and validated an advanced
method for simultaneous detection of antibody responses to
two important swine pathogens. This assay requires a smaller
sample volume and less time than conventional immunoassays
and is more economical and easy to use than two individual
immunoassays. Increasing the multiplexing capability of this
MBA will result in a high-throughput, flexible, and sensitive
platform with practical diagnostic, epidemiological, and dis-
ease surveillance utilities.
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